Allergy Nosode 4017 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Professional Complementary Health Formulas. The primary component is Calcium Sulfide; Fraxinus Latifolia Whole; Guaiac; Histamine; House Dust; Luffa Operculata Fruit; Medicago Sativa Whole; Potassium Dichromate; Silicon Dioxide; Stachybotrys Chartarum; Taraxacum Officinale.
| Product ID | 63083-4017_2a3a5561-22fc-410a-94ab-93af53671529 |
| NDC | 63083-4017 |
| Product Type | Human Otc Drug |
| Proprietary Name | Allergy Nosode 4017 |
| Generic Name | Allergy Nosode |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 1984-08-15 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / |
| Labeler Name | Professional Complementary Health Formulas |
| Substance Name | CALCIUM SULFIDE; FRAXINUS LATIFOLIA WHOLE; GUAIAC; HISTAMINE; HOUSE DUST; LUFFA OPERCULATA FRUIT; MEDICAGO SATIVA WHOLE; POTASSIUM DICHROMATE; SILICON DIOXIDE; STACHYBOTRYS CHARTARUM; TARAXACUM OFFICINALE |
| Active Ingredient Strength | 12 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL |
| Pharm Classes | Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 1985-08-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |